| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |